Literature DB >> 32204962

Practical aspects of inner ear gene delivery for research and clinical applications.

Sungsu Lee1, Anna Dondzillo2, Samuel P Gubbels2, Yehoash Raphael3.   

Abstract

The application of gene therapy is widely expanding in research and continuously improving in preparation for clinical applications. The inner ear is an attractive target for gene therapy for treating environmental and genetic diseases in both the auditory and vestibular systems. With the lack of spontaneous cochlear hair cell replacement, hair cell regeneration in adult mammals is among the most important goals of gene therapy. In addition, correcting gene defects can open up a new era for treating inner ear diseases. The relative isolation and small size of the inner ear dictate local administration routes and carefully calculated small volumes of reagents. In the current review, we will cover effective timing, injection routes and types of vectors for successful gene delivery to specific target cells within the inner ear. Differences between research purposes and clinical applications are also discussed.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32204962      PMCID: PMC7415623          DOI: 10.1016/j.heares.2020.107934

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  151 in total

1.  A truncating mutation in SERPINB6 is associated with autosomal-recessive nonsyndromic sensorineural hearing loss.

Authors:  Asli Sirmaci; Seyra Erbek; Justin Price; Mingqian Huang; Duygu Duman; F Başak Cengiz; Güney Bademci; Suna Tokgöz-Yilmaz; Burcu Hişmi; Hilal Ozdağ; Banu Oztürk; Sevsen Kulaksizoğlu; Erkan Yildirim; Haris Kokotas; Maria Grigoriadou; Michael B Petersen; Hashem Shahin; Moien Kanaan; Mary-Claire King; Zheng-Yi Chen; Susan H Blanton; Xue Z Liu; Stephan Zuchner; Nejat Akar; Mustafa Tekin
Journal:  Am J Hum Genet       Date:  2010-05-06       Impact factor: 11.025

2.  Safety of adeno-associated virus as cochlear gene transfer vector: analysis of distant spread beyond injected cochleae.

Authors:  S T Kho; R M Pettis; A N Mhatre; A K Lalwani
Journal:  Mol Ther       Date:  2000-10       Impact factor: 11.454

3.  Connexin 26 mutations in hereditary non-syndromic sensorineural deafness.

Authors:  D P Kelsell; J Dunlop; H P Stevens; N J Lench; J N Liang; G Parry; R F Mueller; I M Leigh
Journal:  Nature       Date:  1997-05-01       Impact factor: 49.962

Review 4.  Gutless adenovirus: last-generation adenovirus for gene therapy.

Authors:  R Alba; A Bosch; M Chillon
Journal:  Gene Ther       Date:  2005-10       Impact factor: 5.250

5.  Progressive Hearing Loss among Patients with Cystic Fibrosis and Parenteral Aminoglycoside Treatment.

Authors:  Erika M Zettner; Malcolm A Gleser
Journal:  Otolaryngol Head Neck Surg       Date:  2018-06-19       Impact factor: 3.497

6.  Progressive age-dependence and frequency difference in the effect of gap junctions on active cochlear amplification and hearing.

Authors:  Liang Zong; Jin Chen; Yan Zhu; Hong-Bo Zhao
Journal:  Biochem Biophys Res Commun       Date:  2017-05-25       Impact factor: 3.575

7.  The role of Six1 in mammalian auditory system development.

Authors:  Weiming Zheng; Li Huang; Zhu-Bo Wei; Derek Silvius; Bihui Tang; Pin-Xian Xu
Journal:  Development       Date:  2003-09       Impact factor: 6.868

8.  Antioxidant gene therapy can protect hearing and hair cells from ototoxicity.

Authors:  Kohei Kawamoto; Su-Hua Sha; Ryosei Minoda; Masahiko Izumikawa; Hiromichi Kuriyama; Jochen Schacht; Yehoash Raphael
Journal:  Mol Ther       Date:  2004-02       Impact factor: 11.454

Review 9.  Function and Dysfunction of TMC Channels in Inner Ear Hair Cells.

Authors:  David P Corey; Nurunisa Akyuz; Jeffrey R Holt
Journal:  Cold Spring Harb Perspect Med       Date:  2019-10-01       Impact factor: 6.915

10.  Adenovirus Vectors Target Several Cell Subtypes of Mammalian Inner Ear In Vivo.

Authors:  Yilai Shu; Yong Tao; Wenyan Li; Jun Shen; Zhengmin Wang; Zheng-Yi Chen
Journal:  Neural Plast       Date:  2016-12-28       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.